Value
3.0/10data confidence 67%| Component | Sub-score |
|---|---|
| P/S | 1.3 |
| EV/EBITDA | 1.2 |
| p ocf | 6.2 |
| Analyst target | 3.0 |
- ▸P/OCF: 17.7x (FFO proxy — REITs gated off P/E)
- ▸Expensive valuation
OHI · Why this verdict
Why Omega Healthcare Investors (OHI) is rated HOLD
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictHOLD
Overall score6.3/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Omega Healthcare Investors is a healthcare REIT with best-in-class margins of 51%, a strong earnings beat streak of 3 of 4 quarters, and a Rule of 40 score of 56, but the stock is priced near its analyst target with only 1.3% remaining upside and momentum has weakened below the minimum threshold.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Skilled nursing facilities represent 54.6% of Omega's property portfolio, creating regulatory and reimbursement concentration risk since Medicare and Medicaid reimbursement rates directly determine the credit quality of the REIT's tenants. Bear case | Skilled nursing facility exposure declines below 50% of the portfolio over the next 12 months through diversification or selective dispositions. | ↓Deteriorating |
| CounterSkilled nursing facilities are a core competency for Omega and regulatory expertise in this segment can serve as a competitive advantage, with consistent government reimbursement providing predictability. | ||
Omega Healthcare achieved net margins of 51% and ranks highest among peers on both margins and return on equity, reflecting a high-quality portfolio of skilled nursing and other healthcare real estate assets generating superior cash flows. Quality breakdown | Net margin stays above 45% over the next 4 reported quarters, confirming durable portfolio quality. | →Stable |
| CounterHigh margins in a healthcare REIT can partly reflect accounting conventions for real estate income, and a Piotroski F-Score of 7/9 still leaves room for improvement in balance sheet strength. | ||
Omega Healthcare beat earnings estimates in 3 of the last 4 quarters with an average positive surprise of 13.5%, suggesting that management is either conservative in guidance or the business is delivering above expectation operationally. Earnings | Earnings surprise remains positive in at least 3 of the next 4 quarters, sustaining the beat cadence. | →Stable |
| CounterThe most recent quarter was a miss of -3.75%, and beat streaks in REITs can be driven by one-time items such as lease restructurings rather than sustainable operational improvement. | ||
The dividend yield appears high but has been flagged as potentially unsafe, which combined with a momentum score of 4.3 below the minimum threshold of 4.5, suggests the stock may face near-term price pressure that limits total return. Catalyst breakdown | Dividend coverage ratio improves such that funds from operations cover the dividend by more than 1.2x within the next 2 reported quarters. | →Stable |
| CounterThe equity price is above the 200-day moving average and peer-rank quality scores rank Omega as best-in-class, indicating that dividend sustainability concerns may be overstated by the model. | ||
Skilled nursing facilities represent 54.6% of Omega's property portfolio, creating regulatory and reimbursement concentration risk since Medicare and Medicaid reimbursement rates directly determine the credit quality of the REIT's tenants.
↓DeterioratingBear case
- Expectation
- Skilled nursing facility exposure declines below 50% of the portfolio over the next 12 months through diversification or selective dispositions.
CounterSkilled nursing facilities are a core competency for Omega and regulatory expertise in this segment can serve as a competitive advantage, with consistent government reimbursement providing predictability.
Omega Healthcare achieved net margins of 51% and ranks highest among peers on both margins and return on equity, reflecting a high-quality portfolio of skilled nursing and other healthcare real estate assets generating superior cash flows.
→StableQuality breakdown
- Expectation
- Net margin stays above 45% over the next 4 reported quarters, confirming durable portfolio quality.
CounterHigh margins in a healthcare REIT can partly reflect accounting conventions for real estate income, and a Piotroski F-Score of 7/9 still leaves room for improvement in balance sheet strength.
Omega Healthcare beat earnings estimates in 3 of the last 4 quarters with an average positive surprise of 13.5%, suggesting that management is either conservative in guidance or the business is delivering above expectation operationally.
→StableEarnings
- Expectation
- Earnings surprise remains positive in at least 3 of the next 4 quarters, sustaining the beat cadence.
CounterThe most recent quarter was a miss of -3.75%, and beat streaks in REITs can be driven by one-time items such as lease restructurings rather than sustainable operational improvement.
The dividend yield appears high but has been flagged as potentially unsafe, which combined with a momentum score of 4.3 below the minimum threshold of 4.5, suggests the stock may face near-term price pressure that limits total return.
→StableCatalyst breakdown
- Expectation
- Dividend coverage ratio improves such that funds from operations cover the dividend by more than 1.2x within the next 2 reported quarters.
CounterThe equity price is above the 200-day moving average and peer-rank quality scores rank Omega as best-in-class, indicating that dividend sustainability concerns may be overstated by the model.
Per-dimension breakdown
Quality
7.0/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 4.2 |
| ROA | 3.3 |
| Gross margin | 10.0 |
| Op margin | 10.0 |
| Net margin | 10.0 |
| Current ratio | 2.3 |
| FCF quality | 6.0 |
| Moat | 6.9 |
| Rule of 40 | 9.0 |
| Piotroski F | 7.8 |
- ▸Strong margins: 51%
- ▸Rule of 40: 56 (pass)
- ▸Strong Piotroski F-Score: 7/9
Growth
8.0/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 6.1 |
| EPS growth | 9.9 |
Momentum
7.5/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.0 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 3.3 |
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
6.7/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 7.5 |
| Analyst rating | 7.4 |
| Price target | 4.8 |
- ▸LLM news sentiment: +0.50 (n=1)
Insider
7.3/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 10.0 |
| notable moves | 7.0 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
- ▸Institutions accumulating
Peer rank
7.0/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 4.7 |
| quality rank | 9.1 |
| growth rank | 6.9 |
- ▸Attractive P/E vs peers
- ▸Superior ROE vs peers
Technical
3.5/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 0.5 |
| 52w position | 9.9 |
Risk (lower is worse)
6.1/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 7.8 |
| days to cover | 3.9 |
| volatility | 8.0 |
| put call | 0.0 |
| implied vol | 7.3 |
| beta | 9.6 |
| debt equity | 6.1 |
- ▸Elevated put/call: 61.39
- ▸Concentration risks: 1 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
5.5/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 9.3 |
| dividend safety | 2.2 |
| news activity | 5.0 |
- ▸Strong earnings: 3B/1M
- ▸Earnings in 3 days
- ▸Yield trap warning: high yield but unsafe
How the verdict was assembled
Engine trigger
Downgraded from BUY WAIT — price $51.72 has reached target $50.88. No upside to wait for.
Engine technical detail
verdict_path:
L3:NEWS_BLOCK|SANITY:WAIT+price>=TPPassed (5)
- MOMENTUM:7.5>=5.5
- INSIDER:OK
- NEWS_EVENTS:NONE_RECENT
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- ASYMMETRY:-1.4=NEGATIVE
- EARNINGS_PROXIMITY:3d<=7d
Warning (1)
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
-1.40
Upside
-11.4%
Downside
8.2%
Sizing output
AVOID
SetupBreakout — Golden cross, above all MAs, RSI 68, MACD bullish
EdgeNo clear edge — No clear edge identified
SuitabilityModerate — Balanced profile
Investment implication
A recent news event triggered an L3 news-block on the verdict path. Trigger: Downgraded from BUY WAIT — price $51.72 has reached target $50.88. No upside to wait for. The 10-dimension scores remain Growth at 8.0 (strongest), but ASYMMETRY:-1.4=NEGATIVE also fails — the news block is the proximate trigger, not the sole driver.
The strongest dimensions are Growth at 8.0, Momentum at 7.5, and Insider at 7.3; the weakest are Value at 3.0, Technical at 3.5, and Catalyst at 5.5. The V9 engine flagged 2 failed gates with 1 warning, producing an asymmetric reward-to-risk of -1.40 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Best In Class Margins Quality
Trip ifNet margin falls below 40% for 2 consecutive quarters, indicating portfolio quality deterioration.
- P2Earnings Beat Streak
Trip ifEPS surprise falls below -10% in at least 3 of the next 4 quarters, breaking the established beat cadence.
- P3Snf Concentration Risk
Trip ifSkilled nursing facility revenue exposure rises above 60% of total portfolio income, deepening regulatory concentration risk.
- P4Dividend Yield Safety Concern
Trip ifStock price drops below $42, suggesting dividend cut risk or broader sentiment deterioration has materialized.